[2]
Nnamani PO, Hansen S, Windbergs M, Lehr C-M. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application. Int J Pharm 2014; 477: 208-17.
[3]
Peyrottes S, Caldarelli S, Wein S, Perigand C, Pellet A, Vial H. Choline analogues in malaria chemotherapy. Curr Pharm Des 2012; 18: 3454-66.
[4]
van Eijk A. Coverage of malaria protection in pregnant women in sub-saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis 2011; 11: 190-207.
[5]
Fernandez-Busquets X. Heparin-functionalized nanocapsules: enabling targeted delivery of antimalarial drugs. Future Med Chem 2013; 5(7): 737-9.
[6]
Wang D, Li H, Gu J, et al. Ternary system of dihydroartemisinin with hydroxypropyl-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions. J Pharm Biomed Anal 2013; 83: 141-8.
[7]
Cumming JN, Ploypradith P, Posner GH. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol 1997; 37: 253-97.
[8]
Ansari MT, Iqbal I, Sunderland VB. Dihydroartemisinin-cyclodextrin complexation: solubility and stability. Arch Pharm Res 2009; 32(1): 155-65.
[9]
Liu K, Dai L, Li C, Liu J, Wang L, Lei J. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol–dihydroarte-misinin conjugate. Sci Rep 2016; 6: 29461.
[10]
Denis MB, Davis TME, Hewitt S, et al. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin®) in Cambodian children and adults with uncomplicated Falciparum malaria. Clin Infect Dis 2002; 35(12): 1469-76.
[11]
Dai L, Wang L, Deng L, et al. Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer. Sci Rep 2014; 4: 5871.
[12]
Lu WF, Chen SF, Wen ZY, Li Q, Chen JH. In vitro evaluation of efficacy of dihydroartemisinin-loaded methoxypoly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles. J Appl Polym Sci 2013; 128: 3084-92.
[13]
Righeschi C, Coronnello M, Mastrantoni A, et al. Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulations. Colloids Surf B Biointerfaces 2014; 116: 121-7.
[14]
Zhang X, Qiao H, Liu J, et al. Dihydroartemisinin loaded nanostructured lipid carriers (DHA-NLC): evaluation of pharmacokinetics and tissue distribution after intravenous administration to rats. Pharmazie 2010; 65: 670-8.
[15]
Wang S, Wang H, Liang W, Huang Y. An injectable hybrid nanoparticle-in-oil-in-water submicron emulsion for improved delivery of poorly soluble drugs. Nano Res Lett 2012; 7: 219.
[16]
Sun Q, Teong B, Chen IF, Chang SJ, Gao J, Kuo SM. Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells. J Biomed Mater Res Part B Appl Biomater 2014; 102: 455-62.
[17]
Ma W, Xu A, Ying J, Li B, Jin Y. Biodegradable core-shell copolymer-phospholipid nanoparticles for combination chemotherapy: an in vitro study. J Biomed Nanotechnol 2015; 11: 1193-200.
[18]
Kumar S, Singh RK, Murthy RS, Bhardwai TR. Synthesis and evaluation of substituted poly(organo-phosphazenes) as a novel nanocarrier system for combined antimalarial therapy of primaquine and dihydroartemisinin. Pharm Res 2015; 32(8): 2736-52.
[19]
Plaizier-Vercammen J, Gabriels M. . Inclusion complex of artemisinin or derivates thereof with cyclodextrins.WO2004075921A1, 2004.
[20]
Ross CJ. Sublingual spray formulation comprising dihydroartemesinin. WO2010122356A1, 2010.
[21]
Guogiao L, Song J. Composition containing artemisinin for treatment of malaria. US7851512B2 2010.
[22]
Ramreddy S, Kandadi P, Veerabrahma K. Formulation and pharmacokinetics of diclofenac lipid nanoemulsions for parenteral application. PDA J Pharm Sci Technol 2012; 66: 28-37.
[23]
Araujo FA, Kelmann RG, Araujo BV, Finatto RB, Teixeira HF, Koester LS. Development and characterization of parenteral nanoemulsions containing thalidomide. Eur J Pharm Sci 2011; 42: 238-45.
[24]
Dordevic SM, Cekic ND, Savic MM, et al. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: design, characterization and in vivo pharmacokinetic evaluation. Int J Pharm 2015; 493: 40-54.
[25]
Zainol S, Basri M, Basri HB, et al. Formulation optimization of a palm-based nanoemulsion system containing levodopa. Int J Mol Sci 2012; 13: 13049-64.
[26]
Ðordevic SM, Radulovic TS, Cekic ND, et al. Experimental design in formulation of diazepam nanoemulsions: physicochemical and pharmacokinetic performances. J Pharm Sci 2013; 102: 4159-72.
[27]
Umeyor C, Attama A, Uronnachi E, et al. Formulation design and in vitro physicochemical characterization of surface modified self-nanoemulsifying formulations (SNEFs) of gentamicin. Int J Pharm 2016; 497: 161-98.
[28]
Shu G, Khalid N, Tan TB, et al. Comparison of ergocalciferol nanodispersions prepared using modified lecithin and sodium caseinate: insights of formulation, stability, and bioaccessibility. J Funct Foods 2017; 38: 28-35.
[29]
Babalola CP, Oluwalana I, Kotila OA, Adegoke OA, Kolade YT, Ameh SJ. A novel derivatization ultraviolet spectrophotometric method for the determination of dihydroartemisinin using p-nitroaniline. Trop J Pharm Res 2014; 13(1): 127-33.
[30]
nternational Conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Stability testing of new drug substances and products, Q1A (R2), Geneva, Switzerland 2003.
[31]
Rhee Y-S, Park C-W, Nam T-Y, Shin Y-S, Chi S-C, Park E-S. Formulation of parenteral microemulsion containing itraconazole. Arch Pharm Res 2007; 30(1): 114-23.
[32]
Agbo C, Umeyor C, Kenechukwu F, et al. Formulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticles. Drug Dev Ind Pharm 2016; 42(10): 1708-21.
[33]
Baka E, Comer JEA, Takacs-Novak K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 2008; 46: 335-41.
[34]
Doh H-J, Jung Y, Balakrishnan P, Cho H-J, Kim D-D. A novel lipid nanoemulsion system for improved permeation of granisetron. Colloids Surf B Biointerfaces 2013; 101: 475-80.
[35]
Khurana S, Bedi PMS, Jain NK. Development of nanostructured lipid carriers for controlled delivery of mefenamic acid. Int J Biomed Nanosci Nanotechnol 2012; 2(3/4): 232-50.
[36]
Mbah C, Builders P, Nzekwe I, Kunle O, Adikwu M, Attama A. Formulation and in vitro evaluation of pH-responsive ethosomes for vaginal delivery of metronidazole. J Drug Deliv Sci Technol 2014; 24(6): 565-71.
[37]
Pal N, Saxena N, Mandal A. Phase behaviour, solubilization, and phase transition of a microemulsion system stabilized by a novel surfactant synthesized from castor oil. J Chem Eng Data 2017; 62(4): 1278-91.
[38]
Najlah M, Kadan A, Wan K-W, Ahmed W, Taylor KMG, Elhissi AMA. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines. Int J Pharm 2016; 506: 102-9.
[39]
Ali HH, Hussein AA. Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies. AAPS Open 2017; 3: 4.
[40]
Teixeira MC, Severino P, Andreani T, et al. D-α-tocopherol nanoemulsions: size properties, rheological behaviour, surface tension, osmolarity and cytotoxicity. Saudi Pharm J 2017; 25(2): 231-5.
[41]
Kenechukwu FC, Attama AA, Ibezim EC, et al. Novel intravaginal drug delivery system based on molecularly PEGylated lipid matrices for improved antifungal activity of miconazole nitrate. BioMed Res Int 2018; 1-18.
[42]
Awofisayo SO, Igwe CN, Jonathan NA, Francis AI, Ojobor PD. In vitro studies of food interaction with dihydroartemisinin-piperaquine antimalarial tablet. J Pharm Res Int 2017; 18(1): 1-13.
[43]
McClements DJ, Rao J. Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr 2011; 51(4): 285-330.
[44]
Jay AW, Rowlands S. The stages of osmotic haemolysis. J Physiol 1975; 252(3): 817-32.
[45]
Borhade VB, Nair HA, Hegde DD. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech 2008; 9: 13-21.
[46]
Borhade V, Pathak S, Sharma S, Patravale V. Clotrimazole nanoemulsion for malaria chemotherapy. Part II: stability assessment, in vivo pharmacodynamic evaluations and toxicological studies. Int J Pharm 2012; 431: 149-60.
[47]
Basalious EB, Shawky N, Badr-Eldin SM. SNEDDs containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 2010; 391: 203-11.
[48]
Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001; 50: 61-80.
[49]
Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008; 60: 625-37.
81
3
2
2